logo

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Cydex Pharmaceuticals, Inc.


USPTO Granted Patents = 52



Trademarks = 7

Forward Citations = 461

Loading Chart...
Loading Chart...

20 inventors (with patents filed for the assignee):

goldMedal James D Pipkin (26 out of 33 patents)

silverMedal Gerold L Mosher (26 out of 65 patents)

bronzeMedal Vincent D Antle (16 out of 16 patents)

4.  Stephen G Machatha (13 out of 13 patents)

5.  Douglas B Hecker (11 out of 11 patents)

6.  Daniel Joseph Cushing (10 out of 12 patents)

7.  Rupert O Zimmerer (6 out of 6 patents)

8.  Rebecca L Wedel (6 out of 6 patents)

9.  Karen T Johnson (6 out of 7 patents)

10.  Jane A Cowee (6 out of 6 patents)

11.  Diane O Thompson (5 out of 6 patents)

12.  Roger A Rajewski (4 out of 23 patents)

13.  Álvaro Lopes (4 out of 4 patents)

14.  Daniel Monteiro (4 out of 4 patents)

15.  Beau Mainous (3 out of 3 patents)


Core Competencies:
Sulfoalkyl Ether Cyclodextrin
Cyclodextrin Derivatives
Pharmaceutical Compositions
DPI Formulation
Injectable Compositions
Alkylated Cyclodextrin
Nasal Delivery
Ophthalmic Delivery
Silymarin Compositions
Clopidogrel Formulations
Latanoprost Compositions
Inhalant Formulation

52 patents:

1. 12527755 - Formulations containing acetaminophen and sulfoalkyl ether cyclodextrin (2026-01-20),
2. 12390506 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2025-08-19),
3. 12370352 - Nasal and ophthalmic delivery of aqueous corticosteroid solutions (2025-07-29),
4. 11806402 - Sulfoalkyl ether cyclodextrin compositions (2023-11-07),
5. 11795241 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2023-10-24),
6. 11464862 - DPI formulation containing sulfoalkyl ether cyclodextrin (2022-10-11),
7. 11433082 - Composition containing sulfoalkyl ether cyclodextrin and latanoprost (2022-09-06),
8. 11382944 - Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same (2022-07-12),
9. 11208500 - Manufacturing process for cyclodextrin derivatives (2021-12-28),
10. 11020363 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-06-01),
11. 10940128 - Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same (2021-03-09),
12. 10864183 - Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same (2020-12-15),
13. 10851184 - Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same (2020-12-01),
14. 10800861 - Alkylated cyclodextrin compositions and processes for preparing and using the same (2020-10-13),
15. 10799599 - Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid (2020-10-13),
CyDex Pharmaceuticals, Inc. is a leading pharmaceutical company specializing in the development and commercialization of novel drug delivery technologies. With a strong focus on enhancing the solubility and bioavailability of drugs, CyDex offers innovative solutions that improve patient outcomes and enable efficient drug development. Through partnerships and collaborations, CyDex strives to revolutionize drug delivery and contribute to the advancement of healthcare worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

52 Patents

#12 in Emeryville, CA

#1,552 in California

#6,551 in US

#13,183 in the World

...
Emeryville, CA, United States of America

Cydex Pharmaceuticals, Inc.

Forward Citations = 461

20 inventors:

goldMedal James D Pipkin (26 out of 33 patents)

silverMedal Gerold L Mosher (26 out of 65 patents)

bronzeMedal Vincent D Antle (16 out of 16 patents)

4.  Stephen G Machatha (13 out of 13 patents)

5.  Douglas B Hecker (11 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…